Thermogenesis Corporation engages in the development and sale of automated and semi-automated devices used to process, cryopreserve and store therapeutic doses of adult stem cells for treatment of disease and injury. The company's products include ThermoLine freezing and thawing systems, BioArchive and Autoxpress systems used for cell therapy as well as Cryoseal and TPD used in the hospitals for wound care procedures.
For the last quarter ended September 30, 2007, the company's revenue increased by 3% to $3.6 million. However the high cost of revenue and substantial research and development expenditures resulted in the net loss of $2.3...
